Normal view MARC view ISBD view

Development of chewable tablet formulations for cetirizine HCI, levocetirizine HCI, loratadine & domperidone using polysucralose as sweetening agent

By:

Material type: Text

TextPublication details: Lahore (Unpublished) 2016Description: viii, 87 p. : ill. (col.) ; 29 cm. + CDSubject(s):

DDC classification:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	Copy number	Status	Date due	Barcode
Thesis	Lahore Raiwind Campus	615.1 RAS (Browse shelf(Opens below))	1	NOT for LOAN		38571

Previous				No cover image available				Next
Previous	615.1 RAN Rang and dale's pharmacology	615.1 RAN Rang and dale's pharmacology	615.1 RAN Rang and dale's pharmacology	615.1 RAS Development of chewable tablet formulations for cetirizine HCI, levocetirizine HCI, loratadine & domperidone using polysucralose as sweetening agent	615.1 RAT Clinical pharmacology and rational therapeutics	615.1 RAZ Drug design	615.1 REM Remington : the science and practice of pharmacy	Next

Submitted in fulfillment of the requirements for the degree of Master of Philosophy to the Riphah institute of Pharmaceutical Sciences

Includes bibliographical references

Thesis supervisor: Dr. Muhammad Farhan Sohail

English

There are no comments on this title.

to post a comment.

Back to results